A Comparative Clinical Study Of Jalaukavacharna With And Without Local Application Of Mahavajraka Tail In The Management Of Sirajgranthi W.S.R To Varicose Veins
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Following symptoms will be assessed for the reduction in their severity:
Study Overview
Brief Summary
The total of 60 patients will be selected who are between age group of 18 to 65 years of either sex who are diagnosed with Sirajgranthi on the basis of sign and symptoms. Patients will be divided into two groups (Trial Group A and Trial Group B). Group A will be intervene with Jalaukavcharna and Group B will be intervene with Jalaukavcharna along with local application of Mahavajraka Tail and conduct a clinical study - To evaluate the efficacy of Jalaukavcharna in the management of Sirajgranthi w.s.r to Varicose Veins,To evaluate the efficacy of Jalaukavcharna along with local application of Mahavajraka Tail in the management of Sirajgranthi w.s.r to Varicose Veins, To evaluate the difference of efficacy of Jalaukavcharna with and without local application of Mahavajraka Tail in the management of Sirajgranthi w.s.r to Varicose Veins.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Subjects with classical signs and symptoms of Sirajgranthi.
- •Subjects between 18 years to 65 years.
- •Any gender willing and able to participate in the study.
Exclusion Criteria
- •Subjects having chronicity more than 10 years.
- •Pregnant women and lactating women will be excluded.
- •Subjects having any other major complicated diseases like Diabetes Mellitus, Cardiac Diseases, Tuberculosis, HIV, HCV, HBsAg.
- •Subjects diagnosed with Venous Ulcers, Deep Vein Thrombosis, Anemia, Thrombocytopenia will be excluded.
Outcomes
Primary Outcomes
Following symptoms will be assessed for the reduction in their severity:
Time Frame: On Day - 0, 10th, 20th, 30th and 45th Day.
1. Shoola (Pain in Lower Limbs)
Time Frame: On Day - 0, 10th, 20th, 30th and 45th Day.
2. Kandu (Itching)
Time Frame: On Day - 0, 10th, 20th, 30th and 45th Day.
3. Daha (Burning Sensation)
Time Frame: On Day - 0, 10th, 20th, 30th and 45th Day.
4. Shotha (Oedema)
Time Frame: On Day - 0, 10th, 20th, 30th and 45th Day.
5. Sirakunchana (Tortuosity of Veins)
Time Frame: On Day - 0, 10th, 20th, 30th and 45th Day.
6. Skin Changes
Time Frame: On Day - 0, 10th, 20th, 30th and 45th Day.
Secondary Outcomes
- Significant Improvement in the objective parameters.(On Day - 0, 10th, 20th, 30th and 45th Day.)
Investigators
Dr Rohit
Dayanand Ayurvedic College